Results 41 to 50 of about 1,077,721 (136)

Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial [PDF]

open access: yes, 2019
Alcohol use disorder is one of the most prevalent mental health disorders worldwide, treatment options are limited, and relapse rates are high. There remains an urgent need for effective treatments. Research involving the therapeutic potential of classic
Gruppo, Katherine
core   +1 more source

Modalities for Psilocybin-Assisted Psychotherapy: A Review

open access: yes, 2022
This paper will review the current literature on modalities used or proposed for psilocybin-assisted psychotherapy. Modalities have been offered for the treatment of depression, addiction, and the demoralisation of long term AIDS survivors.
Haworth, Nicole
core  

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences

open access: yesScientific Reports, 2023
Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia). These challenging experiences contribute to hesitancy toward psychedelic-assisted psychotherapy among health
Richard J. Zeifman   +7 more
doaj   +1 more source

Unlocking ‘stuckness’ and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic‐assisted therapy for substance use and mental health problems

open access: yesAddiction, EarlyView.
Abstract Background and aims Australia recently down‐scheduled and authorised psychedelic‐assisted therapies, including psilocybin, for certain mental health conditions. Evidence is emerging for potential application in substance use disorder treatment. However, regulatory developments have outpaced implementation readiness.
Sarah J. Catchlove   +3 more
wiley   +1 more source

Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy

open access: yesAddiction, EarlyView.
Abstract Background and aims This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT; BPL‐003) administered alongside psychological
Mathieu Seynaeve   +6 more
wiley   +1 more source

Education for Healthcare Providers: Psilocybin-Assisted Psychotherapy [PDF]

open access: yes
Psilocybin-assisted psychotherapy is emerging as a promising therapeutic modality for addressing psychological distress in psychiatric and palliative care settings.
Carlson, Chelsi
core   +1 more source

Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development

open access: yesFrontiers in Pharmacology, 2018
Mental disorders are rising while development of novel psychiatric medications is declining. This stall in innovation has also been linked with intense debates on the current diagnostics and explanations for mental disorders, together constituting a ...
Eduardo Ekman Schenberg
doaj   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

Obsessive–Compulsive Disorder: Comorbidity, Biomarkers, Circuits, and Treatment Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
OCD has a high comorbidity with other psychiatric conditions, among which anxiety is the most frequent one. The shared genetic biomarkers and common neural circuits underlying the co‐occurrence of OCD and anxiety pave a new path for understanding the pathogenic mechanism of OCD and suggest tailored and integrative treatment therapies for OCD from the ...
Xiao‐Yang Zhang   +9 more
wiley   +1 more source

The influence of psilocybin on subconscious and conscious emotional learning

open access: yesiScience
Summary: Serotonergic psychedelics hold promise as a treatment modality for various psychiatric disorders and are currently applied in psychedelic-assisted psychotherapy.
Andrea F. Casanova   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy